Ahammune Biosciences
Biotech · Pune, IN
Clinical-stage biotech developing small-molecule drugs for vitiligo and immune-mediated skin diseases.
Funding history
| Date | Round | Amount |
|---|
| Sep 2024 | Series A Biotech startup Ahammune Biosciences raised a $5M Series A led by pi Ventures to run phase-2 clinical trials of its vitiligo drug candidate. | $5M |
Investors
Capital2BColossa VenturesIdeaspring CapitalIndian Angel NetworkKotak Alternate Assetspi Ventures
Similar companies in Biotech
Explore funding flow on EquityFlow →